Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway
PMID: 38670405
Source: J Ethnopharmacol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL